Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim Report January - September 2023

The quarter in brief Jul 1st – Sep 30th Jan 1st – Sep 30th 20232023 · Net sales amounted to EUR 11 333 · Net sales amounted thousandto EUR 3 749 thousand (EUR 18 693 thousand in same period last(EUR 5 794 thousand in year)Q3 last year) · EBITDA of EUR 1 158 thousand (EUR 389 · EBITDA of EUR 564 thousand) and EBITDA margin of 10.2%thousand (EUR 24 (2.1%)thousand) and EBITDA · EBIT of EUR 1 050 thousand (75) andmargin of 15% (0.4%) EBIT margin of 9.3% (0.4%) · EBIT

BioStock: Respiratorius’ CEO: “Strong belief but patience regarding agreement”

Lund-based Respiratorius continues talks to reach an agreement regarding the drug candidate VAL001. The discussions are now focused on already established contacts, the company states in its newly released Q3 report. When BioStock contacted CEO Johan Drott to get his view of the past quarter, he was hopeful of reaching an agreement.Read the full article at biostock.se : https://www.biostock.se/en/2023/11/respiratorius-ceo-strong-belief-but-patience-regarding-agreement/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.

Nordea cancels repurchased shares

Nordea Bank AbpStock exchange release – Total number of voting rights and capital17 November 2023 at 9.15 EET Nordea has today cancelled 13,500,394 treasury shares in line with the decision by the Board of Directors. The shares were held for capital optimisation purposes and acquired through share buy-backs. The cancellation brings the total number of shares in Nordea to 3,535,389,326. The total number of votes attached to the shares is 3,535,389,326. The cancellation of the shares was registered with the Finnish Trade Register on 17 November 2023. The company holds 588,029

Assemblin wins a multi-technical installation assignment in a new R&D facility in Lund

Assemblin has been contracted by Skanska to design and install electrical, heating, water, cooling and gas technology in a new R&D facility in Lund (the Höjdpunkten 5 property). The value of the installation assignment is estimated at SEK 85 million.On behalf of property company Vectura, Skanska is to build a new facility of approximately 24,000 m[2] with offices, a laboratory and a test environment. Groundwork has begun and the buildings are scheduled for completion late 2025. Skanska has contracted Assemblin to assume responsibility for the electrical and heating & sanitation

Fortum and Studsvik partner to explore possibilities for new nuclear in Sweden

FORTUM CORPORATION PRESS RELEASE 17.11.2023  Fortum and the Swedish nuclear technology company Studsvik have signed a Memorandum of Understanding (MoU) to explore conditions for new nuclear in Sweden. The collaboration is part of Fortum’s ongoing feasibility study to explore business opportunities in new nuclear both in Finland and Sweden.  The agreement supports Fortum’s strategic priorities to deliver reliable and clean energy and to drive decarbonisation in industries by providing clean energy and CO2-free solutions to its customers.  “A lot of new electricity generation will be

Implantica presents the third quarter 2023 on November 22 at 15:00 CET

Implantica AG (publ) invites investors to a presentation of the third quarter 2023 at 15:00 CET on November 22. The interim report for the third quarter will be published at 8:00 a.m. CET on the same day.The presentation will be in English via an audiocast with teleconference: If you wish to participate via webcast, please use the following link: · https://ir.financialhearings.com/implantica-q3-2023 If you wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the

Truqap approved in US for HR+ breast cancer

17 November 2023 Truqap (capivasertib) plus Faslodex approved in the US for patients with advanced HR-positive breast cancer First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients with specific biomarker alterations (PIK3CA, AKT1 or PTEN) Approval based on CAPItello-291 results which showed this combination reduced the risk of disease progression or death by 50% vs. Faslodex alone in the biomarker-altered population AstraZeneca's Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the US for the treatment of

NCC builds new treatment plant in Österåker, Sweden

NCC has been contracted by Roslagsvatten to build a new treatment plant in Österåker to secure wastewater treatment for Österåker Municipality and the City of Vaxholm. The work will be carried out as a turnkey contract and the order value is approximately SEK 1.2 billion. Image: Skoog Arkitekter On behalf of Roslagsvatten, NCC will build a new wastewater treatment plant alongside the existing one in Margretelund, Åkersberga. Preliminary works have been ongoing for some time and the project is now entering its next phase. This includes advanced work with special ground

Wicket Gaming AB changes its name to edyoutec AB

Wicket Gaming AB (publ) (the "Company") has completed the name change to edyoutec AB, which was voted through at the Extraordinary General Meeting held on 7 November 2023.The company is still listed on Spotlight Stock Market but will go under the name edyoutec. The share will be traded under the name edyoutec with the ticker EDYOU as of 23 November 2023. The new FSIN code is EDYOUTEC/SH.   For further information, please contact: Eric de Basso, CEO, Wicket Gaming ABE-mail: eric@wicketgaming.com  Phone: +46 70 780 52 00 About Wicket GamingWicket Gaming is a Swedish game

Neste and Mitsui Chemicals Group enable food packaging made with renewable materials for CO-OP brand in Japan

Neste Corporation, Press Release, 17 November 2023 at 9.00 a.m. (EET) Photo: CO-OP’s seaweed snack now comes in plastic packaging made with renewable materials. Source: JCCU. · Cooperation enables seaweed snack packaging made with renewable raw materials, further applications planned · First packaging made with renewable plastics via mass balancing that has received the Japanese Eco Mark certification Neste, Mitsui Chemicals and Prime Polymer, a subsidiary of Mitsui Chemicals, are working together to provide more sustainable food packaging solutions for CO-OP, a brand of

Safello Publishes Interim Report for Third Quarter 2023

Stockholm, 17 November 2023 | Today, Safello Group AB (“Safello”) publishes the company’s interim report for the third quarter (1 July–30 September) 2023. The report can be found on safello.com/ir . In the third quarter, there has been stable activity with end of year tailwinds with Swish and Police Authority procurement.  Summary of the third quarter (July–September 2023) · Net turnover decreased by -17% and amounted to SEK 115.3 million (138.8).  · Gross profit decreased by -19% and amounted to SEK 7.3 million (9.0).  ·

Samhällsbyggnadsbolaget i Norden AB’s Nomination Committee appointed

Samhällsbyggnadsbolaget i Norden AB (publ) Nomination Committee for the Annual General Meeting 2024 has been appointed in accordance with the Instruction for the Nomination Committee resolved by the Annual General Meeting 2023. The Nomination Committee consists of: · Ilija Batljan (Ilija Batljan Invest AB) · Rikard Svensson (AB Arvid Svensson) · Leif West (Dragfast AB) · Sven-Olof Johansson (Compactor Fastigheter AB) · Lennart Schuss (the Chair of the Board of Directors) Leif West is the Chair of the Nomination Committee. Shareholders who wish to submit proposals

Studsvik and Fortum partner to explore the possibilities for new nuclear

Studsvik, a nuclear technology company providing safety and efficiency for the global nuclear industry, have signed a Memorandum of Understanding (MoU) with Fortum, a Nordic energy company, to explore the conditions for new nuclear at the Studsvik site outside Nyköping in Sweden.Studsvik wants to support the climate transition, where more nuclear power is needed to meet the climate goals, while also satisfying the increasing demand for energy in all parts of the world. In the long term there is a possibility for new nuclear power on the Studsvik site, either in the form of commercial

Cereno Scientific move to request “compassionate use” of CS1 for treatment of patients with rare disease PAH

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that the company will submit a request for expanded access to investigational drug CS1 for use as a treatment outside of a clinical trial, sometimes called “compassionate use.” The initiative is prompted by a request from an investigator in the ongoing Phase II study of CS1. Cereno will submit a request to the FDA under the ‘Expanded Access to Investigational Drugs for Treatment Use’ requesting expanded access to CS1 which initially will be

Cereno Scientific reports significant progress and a timeline adjustment in the Phase II study of CS1 in rare disease PAH

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced an update on the progress of the Phase II study of CS1 in pulmonary arterial hypertension (PAH). The company reports significant progress in the study, however, a slower recruitment pace than estimated during the last months and a longer start-up phase for two new clinics have affected the study timeline. The updated study timeline now expects study completion and top-line results during Q2 2024.The Phase II study of CS1 in the rare disease

Cereno Scientific secures loan of SEK 90 million, extending the company's financial runway into 2025 and strengthening partnership opportunities

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular diseases, announced today that the Board of Directors of Cereno Scientific has decided to enter into a loan agreement for the total amount of SEK 90 million (the "Loan") issued by Formue Nord Fokus A/S (the "Lender").Background and rationale for the Loan Cereno believes that, with its extensive experience in drug development, strong expert networks, and collaborative partnerships, the company has a significant opportunity to completely transform the treatment of

Shape Robotics publishes Listing Prospectus for listing on Nasdaq Copenhagen Main Market

Company Announcement No. 39-23Copenhagen, 17. November 2023 With reference to company announcements no. 85-2022, 97-2022, 36-2023 and 37-2023, Shape Robotics today announces the publication of a listing prospectus which has been approved by the Danish Financial Supervisory Authority (the “Listing Prospectus”) for the admission to trading and official listing of Shape Robotics’ shares on Nasdaq Copenhagen Main Market (the “Listing”). The Listing Prospectus can be found below in this announcement and at the company’s website .

Interim Financial Report Q3 2023: H+H narrows financial outlook for full-year 2023 and taking further steps to align production with current market demand

Company announcement No. 546, 2023CHIEF EXECUTIVE OFFICER JORG BRINKMANN QUOTE “Our quarterly result is in line with our expectations. Our focus on the business improvement program continues and I am pleased to see first effects coming through, however, we are also impacted by higher energy costs. In light of expected low building activity in the mid-term we have decided to pause production in four factories across our footprint. This will allow us to increase efficiency of the remaining plants, while maintaining a flexible approach to restarting production when market conditions improve.

Interim report January 1 - September 30, 2023

THIRD QUARTER (JULY - SEPTEMBER 2023) · Order intake SEK 240.7 M (219.1) · Net sales SEK 252.9 M (210.9) · Operating profit SEK 28.6 M (12.0) · Profit after tax SEK 21.6 M (10.1) · Earnings per share before/after dilution SEK 0.63 (0.29) · Cash flow SEK 63.5 M (-48.0) · Order backlog SEK 1,966.3 M (1,715.2) at the end of the period NINE MONTHS (JANUARY - SEPTEMBER 2023) · Order intake SEK 686.5 M (704.1) · Net sales SEK 722.5 M (579.3) · Operating profit SEK 70.5 M (22.0) · Profit after tax SEK 50.0 M (9.6) · Earnings per share before/after

Resolution to acquire own shares in Synsam to secure delivery of shares under LTIP 2023

Today, the board of directors of Synsam AB (publ) ("Synsam" or the "Company") has, by exercise of the authorization provided by the annual general meeting held on 25 April 2023, resolved to acquire own shares in order to secure delivery of shares to participants in the Company's long-term incentive program LTIP 2023.According to the board of directors' resolution, own shares may be acquired at one or more occasions during the period 20 November 2023 until and including 31 March 2024. No acquisitions shall however be made during 30 calendar days before publication of an interim or year-end

Interim report January-September 2023 NOBA Bank Group AB (publ)

Highlights July-September 2023 (Previous quarter in parenthesis) · Solid growth where all active markets and products contributed to the increase in volume · Total lending amounted to SEK 107.8 billion (101.5) · Personal loans and credit cards amounted to SEK 90.5 billion (84.7) · Mortgage lending (mortgage loans and equity release mortgages) amounted to SEK 17.2 billion (16.7), comprising 16% of total lending · The savings offering continued to grow and total deposits amounted to SEK 93.7 billion (87.2) · Reported operating profit amounted to SEK 373 million (454)

Interim report January-September 2023 NOBA Holding AB (publ)

Highlights July-September 2023 (Previous quarter in parenthesis) · Solid growth where all active markets and products contributed to the increase in volume · Total lending amounted to SEK 108.3 billion (102.1) · Personal loans and credit cards amounted to SEK 91.0 billion (85.3) · Mortgage lending (mortgage loans and equity release mortgages) amounted to SEK 17.2 billion (16.7), comprising 16% of total lending · The savings offering continued to grow and total deposits amounted to SEK 93.7 billion (87.2) · Reported operating profit amounted to SEK 327 million (425)

Synsam Group’s Q3 report 2023

Focus on profitable growth yields results - "EBIT increased 38 percent in the third quarter”1 July - 30 September 2023 · Net sales amounted to SEK 1,450 million (1,319), up 9.9 percent. Organic growth totalled 7.0 percent (9.6) · Net sales from spectacles subscriptions increased 13.7 percent (23.4) · The gross margin increased to 74.9 percent (73.8) · EBITDA[1] rose to SEK 373 million (303) and the EBITDA margin was 25.2 percent (22.7) · EBITA increased to SEK 222 million (169) and the EBITA margin was 15.0 percent (12.7) · EBIT increased to SEK 184 million (133) and the

SRV and the City of Espoo terminate their agreement for the basic renovation and extension of the Tapiola swimming hall

SRV GROUP PLC     INVESTOR NEWS    17 NOVEMBER 2023   08.15 EEST SRV and the City of Espoo terminate their agreement for the basic renovation and extension of the Tapiola swimming hall SRV and the City of Espoo’s Premises Services Unit have decided to terminate their agreement for the basic renovation of the Tapiola swimming hall. Solutions for reaching the client’s target budget were sought during the project’s development phase. However, in spite of close operation, no solution was reached on the project’s financial objectives during ten months of extensive development work. The

There are no items matching the current filter
There are no more items matching the current filter
Back to top